Banner of CND: United Nations Commission on Narcotic Drugs, policymaking body of the United Nations system with prime responsibility for drug-related matters

Drug-related resolutions and decisions 2020 to 2029

The resolutions and decisions database offers for full text search and sorting:

  

  

 

2020 

CND

Resolution 63/1

Promoting efforts by Member States to address and counter the world drug problem, in particular supply reduction-related measures, through effective partnerships with private sector entities

Resolution 63/2

Promoting and improving the collection and analysis of reliable and comparable data to strengthen balanced, integrated, comprehensive, multidisciplinary and scientific evidence-based responses to the world drug problem

Resolution 63/3

Promoting awareness-raising, education and training as part of a comprehensive approach to ensuring access to and the availability of internationally controlled substances for medical and scientific purposes and improving their rational use

Resolution 63/4

Promoting the involvement of youth in drug prevention efforts

Resolution 63/5

Promoting alternative development as a development-oriented drug control strategy

Decision 63/1

Inclusion of methyl alpha-phenylacetoacetate (MAPA), including its optical isomers, in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988

Decision 63/2

Inclusion of crotonylfentanyl in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol

Decision 63/3

Inclusion of valerylfentanyl in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol

Decision 63/4

Inclusion of DOC in Schedule I of the of the Convention on Psychotropic Substances of 1971

Decision 63/5

Inclusion of AB-FUBINACA in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 63/6

Inclusion of 5F-AMB-PINACA (5F-AMB, 5F-MMB-PINACA) in Schedule II of the Convention on Psychotropic Substances of 1971    

Decision 63/7

Inclusion of 5F-MDMB-PICA (5F-MDMB-2201) in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 63/8

Inclusion of 4F-MDMB-BINACA in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 63/9

Inclusion of 4-CMC (4-chloromethcathinone, clephedrone) in Schedule II of the Convention on Psychotropic Substances of 1971  

Decision 63/10

Inclusion of N-ethylhexedrone in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 63/11

Inclusion of alpha-PHP in Schedule II of the Convention on Psychotropic Substances of 1971

Decision 63/12

Inclusion of flualprazolam in Schedule IV of the Convention on Psychotropic Substances of 1971

Decision 63/13

Inclusion of etizolam in Schedule IV of the Convention on Psychotropic Substances of 1971

Decision 63/14

Changes in the scope of control of substances: proposed scheduling recommendations by the World Health Organization on cannabis and cannabis-related substances

Decision 63/15

Improved and streamlined annual report questionnaire